A Study of Tarceva for Use in Patients With Relapsed or Refractory Metastatic Non-Small Cell Lung Cancer
Clinical trial NCT00283634 · TERMINATED
Trial details
- NCT number
- NCT00283634
- Sponsor
- Millennium Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-08-01
- Primary completion
- 2007-07-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.